Wildcat Capital Management, LLC — 13F Holdings & Portfolio

CIK 1582384 · latest 13F-HR filed 2026-05-01

Wildcat Capital Management, LLC manages $106.2M in 13F-reported U.S. long-equity assets across 2 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are ULCC (93.29%), ALLO (6.71%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 1, added to 1, and trimmed 1.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$106.2M

Long-equity book

Holdings

2

Distinct positions

Period

2026-03-31

Filed 2026-05-01

Q/Q Activity

+0 / −1 / ↑1 / ↓1

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • ALLOGENE THERAPEUTICS INC$3.1M +78.1%
Show all 1

Top Trims

  • FRONTIER GROUP HLDGS INC-$33.1M -25.1%
Show all 1

New Positions

  • No new positions this quarter.
Show all 0

Exited Positions

  • PROCORE TECHNOLOGIES INC$280.1K
Show all 1
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 FRONTIER GROUP HLDGS INC ULCC 35909R108 $99.1M 93.29% 28,061,351 SH
2 ALLOGENE THERAPEUTICS INC ALLO 019770106 $7.1M 6.71% 2,920,787 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-01 $106.2M 2 0001999371-26-009738
2025-12-31 2026-02-03 $136.5M 3 0001999371-26-002481